Several studies support COVID-19 vaccine boosters as FDA remains neutral ahead of Friday vote

Several studies published Wednesday supporting potential use of Pfizer's COVID-19 vaccine booster shot amid waning immunity met a neutral tone from the Food and Drug Administration, per documents posted ahead of a critical meeting Friday.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.